Sophie, Duchess of Edinburgh, took part in a roundtable conversation, hosted by the UK Mission to the EU and European Parliaments Intergroup on Children’s Rights, in Brussels, Belgium this week.

Approximately 93.8% of the votes cast at the EGM were in favor of the Business Combination. In addition, in order to extend the date by which AIMA must complete the Business Combination from March ...

Pakistan: Losartan, a widely used angiotensin II receptor blocker for hypertension, has recently been recognized for its potential therapeutic effects beyond blood pressure regulation. Research ...

John­son & John­son re­leased new da­ta sug­gest­ing its lung can­cer com­bi­na­tion Ry­bre­vant and Laz­cluze beat As­traZeneca’s Tagris­so on over­all sur­vival.

All products are independently selected by our editors. If you buy something, we may earn an affiliate commission. No need to waste time in the morning wondering what to wear when baggy jeans and ...

However, if you're looking for a simpler setup without overspending, finding the best budget modem router combo for your home is the way to go. A modem router combo combines both devices into one. The ...

The combo also brought about a 19% reduction in risk of death from any cause; a 16% reduction in heart-related deaths; an 18% decrease in the risk of a major cardiovascular health problem ...

The theatrical release of “Eraserheads: Combo on the Run,” a documentary film about the legendary OPM band Eraserheads, has been extended for an additional week, citing “persistent public ...

The rationale behind low-dose combination therapy is the use of ... a common side effect of the dihydropyridine CCBs (for example, amlodipine and nifedipine) occurs as a result of the very ...

Arbli is supplied as an peppermint-flavored oral suspension containing 10mg/mL of losartan potassium in 165mL bottles. The Food and Drug Administration (FDA) has approved Arbli ™, an oral suspension ...

The fixed drug combination of aliskiren and amlodipine (trade name: Rasilamlo) was approved in April 2011 for the treatment of people with hypertension in whom aliskiren or amlodipine alone has an ...

The FDA has once again issued a complete response letter to Hengrui and Elevar’s applications for camrelizumab and the VEGFR inhibitor rivoceranib as a combination for the first-line treatment ...